Cellular Biomedicine Group Company Profile (NASDAQ:CBMG)

About Cellular Biomedicine Group

Cellular Biomedicine Group logo

Cellular Biomedicine Group, Inc. (CBMG) is a biomedicine company. The Company is engaged in the development of treatments for cancerous and degenerative diseases utilizing cell-based technologies. The Company operates in Biomedicine Cell Therapy segment. The Company's technology includes platforms, such as Immune Cell therapy for treatment of broad range of cancers using Vaccine, T Cells Receptor (TCR) clonality analysis technology and T Central Memory Cell (Tcm) preparation methodologies, Chimeric Antigen Receptor T cell (CAR-T), and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases, with primary research and manufacturing facilities in China. It is focused on developing and marketing cell-based therapies based on its cellular platforms, to treat serious chronic and degenerative diseases, such as cancer, orthopedic diseases, including osteoarthritis and tissue damage, various inflammatory diseases and metabolic diseases.

Industry, Sector and Symbol:

Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: CBMG
CUSIP:

Key Metrics:

Previous Close: $14.50
50 Day Moving Average: $14.17
200 Day Moving Average: $15.29
52-Week Range: $10.44 - $25.20
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -7.29
P/E Growth: 0.00
Market Cap: $204.48M
Outstanding Shares: 14,102,000
Beta: 2.85

Profitability:

Net Margins: -1,192.75%
Return on Equity: -34.05%
Return on Assets: -31.89%

Debt:

Current Ratio: 22.45%
Quick Ratio: 22.31%

Additional Links:

Companies Related to Cellular Biomedicine Group:

Consensus Ratings for Cellular Biomedicine Group (NASDAQ:CBMG) (?)

Ratings Breakdown:	1 Buy Rating
Consensus Rating:	Buy (Score: 3.00)
Consensus Price Target:	$16.00 (10.34% upside)

Analysts' Ratings History for Cellular Biomedicine Group (NASDAQ:CBMG)

Show:

Date	Firm	Action	Rating	Price Target	Details
9/22/2016	Maxim Group	Initiated Coverage	Buy	$16.00

(Data available from 9/30/2014 forward)

Earnings History for Cellular Biomedicine Group (NASDAQ:CBMG)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Release Link	Conference Call
11/11/2016
3/14/2016	Q415	($0.42)	($0.43)	$1.50 million	View	N/A
11/13/2015	Q3	($0.43)	($0.44)		View	N/A
8/14/2015	Q215	($0.37)	($0.44)		View	N/A
5/18/2015	Q115	($0.40)	($0.39)		View	N/A
3/31/2015		($0.32)	($0.57)		View	N/A
11/19/2014	Q314		($0.31)		View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Cellular Biomedicine Group (NASDAQ:CBMG)

Current Year EPS Consensus Estimate: $-1.83 EPS
Next Year EPS Consensus Estimate: $-1.99 EPS

Dividend History for Cellular Biomedicine Group (NASDAQ:CBMG)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Cellular Biomedicine Group (NASDAQ:CBMG)

Insider Ownership Percentage: 7.30%
Institutional Ownership Percentage: 8.71%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/22/2016	Andrew K Chan	SVP	Sell	1,307	$18.22	$23,813.54
2/17/2016	Andrew K. Chan	SVP	Sell	1,516	$17.76	$26,924.16
1/21/2016	Andrew K. Chan	SVP	Sell	2,812	$12.90	$36,274.80
12/21/2015	Andrew K. Chan	SVP	Sell	12,812	$21.94	$281,095.28
11/23/2015	Andrew K. Chan	SVP	Sell	5,332	$20.64	$110,052.48
10/21/2015	Wei (William) Cao	CEO	Sell	20,000	$19.59	$391,800.00
10/20/2015	Andrew K. Chan	SVP	Sell	5,215	$20.20	$105,343.00
9/21/2015	Andrew K. Chan	SVP	Sell	27,927	$20.80	$580,881.60
12/23/2014	Pak To Leung	Major Shareholder	Sell	142,857	$14.00	$1,999,998.00
6/26/2014	David Bolocan	Director	Buy	10,000	$5.00	$50,000.00
5/22/2014	Tony Liu	CFO	Buy	100,000	$5.00	$500,000.00
7/23/2013	Keith Wong	Director	Sell	320,050	$0.13	$41,606.50

(Data available from 1/1/2013 forward)

Latest Headlines for Cellular Biomedicine Group (NASDAQ:CBMG)

Date	Headline
	CELLULAR BIOMEDICINE GROUP, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Shareholder Director Nominations (form 8-K) (NASDAQ:CBMG) www.4-traders.com - September 22 at 9:45 AM
	CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, (NASDAQ:CBMG) biz.yahoo.com - September 22 at 9:45 AM
	Coverage initiated on Cellular Biomedicine by Maxim Group (NASDAQ:CBMG) finance.yahoo.com - September 22 at 9:45 AM
	Cellular Biomedicine Group Announces Results of 2016 Annual General Meeting (NASDAQ:CBMG) finance.yahoo.com - September 10 at 8:48 AM
	CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Regulation (NASDAQ:CBMG) biz.yahoo.com - September 10 at 8:48 AM
	ETF’s with exposure to Cellular Biomedicine Group, Inc. : September 9, 2016 (NASDAQ:CBMG) www.capitalcube.com - September 9 at 4:00 PM
	ETF’s with exposure to Cellular Biomedicine Group, Inc. : August 29, 2016 (NASDAQ:CBMG) www.capitalcube.com - August 29 at 3:28 PM
	Cellular Biomedicine : Announces Dismissal of Class Action Litigation (NASDAQ:CBMG) www.4-traders.com - August 19 at 11:39 AM
	Cellular Biomedicine Group Announces Dismissal of Class Action Litigation (NASDAQ:CBMG) finance.yahoo.com - August 18 at 12:31 PM
	CELLULAR BIOMEDICINE GROUP, INC. Financials (NASDAQ:CBMG) finance.yahoo.com - August 17 at 4:12 PM
	ETF’s with exposure to Cellular Biomedicine Group, Inc. : August 17, 2016 (NASDAQ:CBMG) www.capitalcube.com - August 17 at 4:12 PM
	Cerebral Palsy Pipeline Market 2016 Global Review Research (NASDAQ:CBMG) www.fox8live.com - August 16 at 9:22 PM
	Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:CBMG) www.capitalcube.com - August 15 at 4:17 PM
	Cellular Biomedicine Group Reports Second Quarter and First Half 2016 Financial Results and Business Highlights (NASDAQ:CBMG) www.streetinsider.com - August 10 at 11:46 AM
	Cellular Biomedicine reports 2Q loss (NASDAQ:CBMG) sg.finance.yahoo.com - August 9 at 1:01 PM
	UPDATE -- Cellular Biomedicine Group Reports Second Quarter and First Half 2016 Financial Results and Business Highlights (NASDAQ:CBMG) finance.yahoo.com - August 9 at 1:01 PM
	Cellular Biomedicine Group Announces Annual General Meeting of Stockholders (NASDAQ:CBMG) finance.yahoo.com - August 1 at 8:30 AM
	Cellular Biomedicine : Announces Appointment of New Member to the Board of Directors (NASDAQ:CBMG) www.4-traders.com - July 13 at 9:30 PM
	Cellular Biomedicine Group Announces Appointment of New Member to the Board of Directors (NASDAQ:CBMG) finance.yahoo.com - July 12 at 8:30 AM
	5:27 am Cellular Biomedicine to issue up to 5,137,905 shares of common stock for sale by selling shareholders (NASDAQ:CBMG) finance.yahoo.com - June 21 at 5:27 AM
	ETF’s with exposure to Cellular Biomedicine Group, Inc. : June 17, 2016 (NASDAQ:CBMG) www.capitalcube.com - June 17 at 5:08 PM
	Systemic lupus erythematosus pipeline market review 2016 insights shared in detailed report (NASDAQ:CBMG) www.whatech.com - June 7 at 12:21 PM
	CELLULAR BIOMEDICINE GROUP, INC. : Shareholder Director Nominations (form 8-K) (NASDAQ:CBMG) www.4-traders.com - May 25 at 7:18 PM
	CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Shareholder Director Nominations (NASDAQ:CBMG) biz.yahoo.com - May 25 at 11:02 AM
	Biotech Class Action Must Be Amended (NASDAQ:CBMG) www.courthousenews.com - May 24 at 11:18 AM
	ETF’s with exposure to Cellular Biomedicine Group, Inc. : May 23, 2016 (NASDAQ:CBMG) www.capitalcube.com - May 23 at 4:53 PM
	Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016 (NASDAQ:CBMG) www.capitalcube.com - May 23 at 1:25 PM
	Morning Biggest Movers – LTBR, ATRM, OSUR, SGYP, CBMG, CCXI, OHGI (NASDAQ:CBMG) www.fxpips.com - May 19 at 10:49 AM
	BRIEF-Cellular Biomedicine reports Q1 results (NASDAQ:CBMG) www.reuters.com - May 9 at 7:32 PM
	Cellular Biomedicine : Reports First Quarter 2016 Financial Results and Provides Business Highlights (NASDAQ:CBMG) www.4-traders.com - May 9 at 7:32 PM
	Cellular Biomedicine reports 1Q loss (NASDAQ:CBMG) sg.finance.yahoo.com - May 9 at 5:18 PM
	Cellular Biomedicine Group Reports First Quarter 2016 Financial Results and Provides Business Highlights (NASDAQ:CBMG) finance.yahoo.com - May 9 at 4:01 PM
	CELLULAR BIOMEDICINE GROUP, INC. : Change in Directors or Principal Officers (form 8-K) (NASDAQ:CBMG) www.4-traders.com - May 5 at 7:58 PM
	CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CBMG) biz.yahoo.com - May 5 at 12:21 PM
	RSI Alert: Cellular Biomedicine Group (CBMG) Now Oversold (NASDAQ:CBMG) www.thestreet.com - May 4 at 7:39 PM
	CELLULAR BIOMEDICINE GROUP, INC. : Unregistered Sale of Equity Securities, Other Events (form 8-K) (NASDAQ:CBMG) www.4-traders.com - April 20 at 7:56 PM
	CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events (NASDAQ:CBMG) biz.yahoo.com - April 20 at 5:14 PM
	Dangdai International Makes $43.1M Strategic Investment in Cellular Biomedicine Group (CBMG) (NASDAQ:CBMG) www.streetinsider.com - April 19 at 8:13 PM
	Cellular Biomedicine Group Announces Closing of $43.13 Million Strategic Investment from Dangdai International Group Co., Limited, a Wholly-Owned Hong Kong Subsidiary of Wuhan Dangdai Science & Technology Industries Group Inc. (NASDAQ:CBMG) finance.yahoo.com - April 19 at 8:30 AM
	ETF’s with exposure to Cellular Biomedicine Group, Inc. : March 23, 2016 (NASDAQ:CBMG) www.capitalcube.com - March 23 at 3:09 PM
	Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: Q4, 2015 By the Numbers (NASDAQ:CBMG) www.capitalcube.com - March 21 at 1:16 PM
	Cellular Biomedicine Group, Inc. :CBMG-US: Earnings Analysis: 2015 By the Numbers (NASDAQ:CBMG) www.capitalcube.com - March 21 at 10:46 AM
	Cellular Biomedicine Group Reports Full-Year 2015 Financial Results and Recent Operational Progress (NASDAQ:CBMG) finance.yahoo.com - March 14 at 7:00 AM
	CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 10-K, Annual Report (NASDAQ:CBMG) biz.yahoo.com - March 14 at 6:08 AM
	Cellular Biomedicine Group Inc. (CBMG) (NASDAQ:CBMG) finance.yahoo.com - February 21 at 10:24 AM
	Fundraisings highlight the rise in Chinese pharma R&D (NASDAQ:CBMG) www.ft.com - February 18 at 5:49 PM
	Dangdai Invests Over US$43 Million In CBMG (NASDAQ:CBMG) www.asianscientist.com - February 12 at 10:24 AM
	CELLULAR BIOMEDICINE GROUP, INC. Files SEC form 8-K, Unregistered Sale of Equity Securities, Other Events, Financial (NASDAQ:CBMG) biz.yahoo.com - February 10 at 5:17 PM
	SCLN Settles FCPA Charges, OGXI On Cost Discipline Mode, Shire To Face FDA (NASDAQ:CBMG) www.nasdaq.com - February 5 at 10:00 AM
	Cellular Biomedicine Group (CBMG) Receives $43M Strategic Investment From Dangdai International (NASDAQ:CBMG) www.streetinsider.com - February 5 at 10:00 AM